Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia.

Circ Genom Precis Med 2018 08;11(8):e002146

Genomic Medicine Institute (A.K.R., K.M., L.B., A.L., T.C., D.K., A.C.S., M.F.M.).

Background: The MyCode Community Health Initiative (MyCode) is returning actionable results from whole exome sequencing. Familial hypercholesterolemia (FH) is an inherited condition characterized by premature cardiovascular disease.

Methods: We used multiple methods to assess care in 28 MyCode participants who received FH results. Chart reviews were conducted on 23 individuals in the sample and 7 individuals participated semistructured interviews.

Results: Chart reviews for 23 individuals with a Geisinger primary care provider found that 4 individuals (17% of 23) were at LDL-C (low-density lipoprotein cholesterol) goal (of either LDL-C <100 mg/dL for primary prevention and LDL-C <70 mg/dL for secondary prevention) and 17 individuals (74% of 23) were prescribed lipid-lowering therapy before genetic result disclosure. After disclosure of the genetic test result, 5 individuals (22% of 23) met their LDL-C goal and 18 individuals (78% of 23) were prescribed lipid-lowering therapy. Follow-up care about this result was not documented for 4 individuals (17% of 23). Changes to intensity of medication management were made for 8 individuals (47% of 17 individuals previously prescribed lipid-lowering therapy). Interviewed individuals (n=7) were not surprised by their result as all knew they had high cholesterol; however, individuals did not seem to discern FH as a separate condition from their high cholesterol.

Conclusions: Among individuals receiving genetic diagnosis of FH, >25% had no changes to lipid-lowering therapy, despite not being at LDL-C goal and learning their high cholesterol is related to a genetic condition requiring more aggressive treatment. Individuals and clinicians may have an inadequate understanding of FH as a distinct condition requiring enhanced medical management.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCGEN.118.002146DOI Listing
August 2018
2 Reads

Publication Analysis

Top Keywords

chart reviews
8
familial hypercholesterolemia
8
participants received
4
received chart
4
reviews conducted
4
individuals
4
individuals sample
4
conducted individuals
4
mycode participants
4
care mycode
4
characterized premature
4
condition characterized
4
inherited condition
4
premature cardiovascular
4
cardiovascular diseasemethods
4
assess care
4
methods assess
4
multiple methods
4
sample individuals
4
individuals participated
4

References

(Supplied by CrossRef)
Familial hypercholesterolemia: developments in diagnosis and treatment.
Klose G et al.
Dtsch Arztebl Int 2014

Youngblom E et al.
1993

Similar Publications